Portfolio company
R3 Vascular Inc.
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bioresorbable sirolimus-coated vascular scaffolds for clinicians treating patients with peripheral arterial disease below the knee.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Intact Vascular
The company develops minimally invasive medical devices for treating peripheral artery disease and post-angioplasty dissections in patients and clinicians.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
iCHOR Vascular
This company develops minimally invasive mechanical thrombectomy devices for clinicians to remove blood clots from peripheral arteries and veins.
VASCULAR THERAPIES
This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.
AtheroMed
This company develops a catheter system that removes plaque from arteries for physicians treating patients with peripheral artery disease.
Evident Vascular
This company develops an artificial intelligence powered intravascular ultrasound platform and catheters for clinicians performing peripheral and coronary vascular interventions.
Intelvasc
This company develops implantable sensors and monitoring systems to track blood flow and vascular occlusions for patients with peripheral arterial disease.
SELUTION SLR
This company manufactures drug-eluting balloons for interventional cardiologists to treat patients with coronary and peripheral artery diseases.
